DE602005013650D1 - Proteinhydrolysat zur behandlung von müdigkeit - Google Patents

Proteinhydrolysat zur behandlung von müdigkeit

Info

Publication number
DE602005013650D1
DE602005013650D1 DE602005013650T DE602005013650T DE602005013650D1 DE 602005013650 D1 DE602005013650 D1 DE 602005013650D1 DE 602005013650 T DE602005013650 T DE 602005013650T DE 602005013650 T DE602005013650 T DE 602005013650T DE 602005013650 D1 DE602005013650 D1 DE 602005013650D1
Authority
DE
Germany
Prior art keywords
tiredness
treatment
protein hydrolysate
hydrolysate
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005013650T
Other languages
English (en)
Inventor
Tomohiro Kodera
Noriki Nio
Hitoshi Murakami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of DE602005013650D1 publication Critical patent/DE602005013650D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/346—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/347—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of proteins from microorganisms or unicellular algae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE602005013650T 2004-02-24 2005-02-07 Proteinhydrolysat zur behandlung von müdigkeit Active DE602005013650D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004048417A JP2005239579A (ja) 2004-02-24 2004-02-24 疲労回復剤及び疲労回復用食品
PCT/JP2005/001752 WO2005079826A1 (ja) 2004-02-24 2005-02-07 疲労回復剤及び疲労回復用食品

Publications (1)

Publication Number Publication Date
DE602005013650D1 true DE602005013650D1 (de) 2009-05-14

Family

ID=34879510

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005013650T Active DE602005013650D1 (de) 2004-02-24 2005-02-07 Proteinhydrolysat zur behandlung von müdigkeit

Country Status (5)

Country Link
US (2) US20080009440A1 (de)
EP (1) EP1721616B1 (de)
JP (1) JP2005239579A (de)
DE (1) DE602005013650D1 (de)
WO (1) WO2005079826A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007119590A1 (ja) * 2006-03-31 2009-08-27 日清ファルマ株式会社 小麦由来の血圧低下用組成物
JP5775657B2 (ja) * 2006-06-13 2015-09-09 株式会社明治 アミノ酸組成物を含有する疲労防止剤
JP5317501B2 (ja) * 2008-03-14 2013-10-16 月桂冠株式会社 疲労軽減剤
MX2015011771A (es) 2013-03-08 2016-12-07 Axiom Foods Inc Suplemento de proteínas de arroz y métodos de uso de este.
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
EP4035671A4 (de) * 2019-09-26 2023-09-27 Morinaga Milk Industry Co., Ltd. Zusammensetzung zur aktivierung eines sympathischen nervs
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63287462A (ja) * 1987-05-21 1988-11-24 Fuji Oil Co Ltd ペプチド栄養剤
JPH01269456A (ja) * 1988-04-20 1989-10-26 Fuji Oil Co Ltd スポーツ用食品
DK0518999T3 (da) * 1990-03-09 1995-12-18 Novo Nordisk As Proteinhydrolysater
JP3503220B2 (ja) * 1994-04-21 2004-03-02 味の素株式会社 新規チオールプロテアーゼ
JP2000083695A (ja) * 1998-09-16 2000-03-28 Ajinomoto Co Inc 低苦味ペプチドの製造法

Also Published As

Publication number Publication date
US20090203604A1 (en) 2009-08-13
WO2005079826A1 (ja) 2005-09-01
EP1721616B1 (de) 2009-04-01
US20080009440A1 (en) 2008-01-10
JP2005239579A (ja) 2005-09-08
EP1721616A4 (de) 2008-02-20
EP1721616A1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
CY2016039I2 (el) Χιμαιρικες πρωτεϊνες παραγοντα πηξης για την αγωγη αιμοστατικων ασθενειων
ATE369333T1 (de) Sulfonamidderivate zur behandlung von krankheiten
DE60325209D1 (de) Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
DE602004028763D1 (de) Te zur behandlung von virenerkrankungen
DE602005019899D1 (de) System zur behandlung von ischämischem schlaganfall
DE602004022061D1 (de) Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
ATE524479T1 (de) Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
ATE493986T1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
DE502005010499D1 (de) Implantat zur Behandlung von Fettsucht
ATE521365T1 (de) Kinin-antagonisten zur behandlung von blasenfunktionsstörung
DE602005013650D1 (de) Proteinhydrolysat zur behandlung von müdigkeit
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
ATE503752T1 (de) Sulfamide alsendothelinrezeptorantagonsiten zur behandlung von herzkreislauferkrankungen
DE602005015434D1 (de) Mittel zur behandlung von psychoneurotischen krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition